Nuclear in Science and Medicine

In the century or so since the start of nuclear science, we’ve made many useful discoveries. Nuclear medicine covers diagnosing diseases, treating patients with cancer and sterilizing gowns, gloves, masks, syringes and implants. What are the next exciting frontiers? Find out during a panel presentation on February 28 from 10:30 to 11:30 at CNA2020.

As the Technical and Business Director for Medical Isotopes at Kinectrics, Travis Besanger is responsible for building a strong value chain for Kinectrics’s products and for establishing a state-of-the-art isotope processing centre at the company’s Teeswater, Ontario, location. Before joining Kinectrics in 2019, he had 13 years of experience in the radiopharmaceutical industry. Most of that was at the Centre for Probe Development and Commercialization, where he led commercialization of radiopharmaceuticals and medical isotope products.

Thomas R. Burnett is Vice-President and General Manager of BWXT Isotope Technology Group (ITG) Canada. He is responsible for all aspects in the establishment and direction of the BWXT ITG Canada operation. Before joining BWXT in 2017, Burnett had varying levels of responsibility in the nuclear medicine industry related to marketing. He has worked in sales, general management and consulting at Nordion, Thermo Fisher Scientific, Ernst & Young and Merck Frosst.

Karen Mossman is the Associate Vice-President of Research at McMaster University. Mossman joined McMaster in 2001 with a research focus on understanding the interactions between viruses and their hosts, both in normal healthy cells and in cancer cells. The Department of Pathology and Molecular Medicine Professor’s goal is to develop novel therapy approaches for emerging viral infections and cancer. She also serves as Chair of the Board of the McMaster Innovation Park.

Find the complete CNA2020 schedule at https://cna.ca/cna2020/program/.

To register for the conference, visit https://cna.ca/cna2020/registration/.